Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0002076625-25-000003
Filing Date
2025-07-11
Accepted
2025-07-11 08:38:21
Documents
1
Effectiveness Date
2025-07-11
Items
Item 04: Rule 504(b)(1) (not (i), (ii) or (iii))
Item 04.1: Rule 504(b)(1)(i)
Item 04.2: Rule 504(b)(1)(ii)
Item 04.3: Rule 504(b)(1)(iii)
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.10: Section 3(c)(10)
Item 3C.11: Section 3(c)(11)
Item 3C.12: Section 3(c)(12)
Item 3C.13: Section 3(c)(13)
Item 3C.14: Section 3(c)(14)
Item 3C.2: Section 3(c)(2)
Item 3C.3:
Item 3C.4: Section 3(c)(4)
Item 3C.5: Section 3(c)(5)
Item 3C.6: Section 3(c)(6)
Item 3C.7: Section 3(c)(7)
Item 3C.9: Section 3(c)(9)
Item 4a5:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6620
  Complete submission text file 0002076625-25-000003.txt   8744
Mailing Address 32 LONDON BRIDGE ST LONDON UNITED KINGDOM United Kingdom SE1 9SG
Business Address 32 LONDON BRIDGE ST LONDON UNITED KINGDOM United Kingdom SE1 9SG 008613959148038
PHYXTRADE LTD (Filer) CIK: 0002076625 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-551227 | Film No.: 251117589